Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2025-02-27 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金购买理财产品进展的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the company's use of idle funds to purchase financial products, including specifics on amounts, counterparties, investment types, risk controls, and disclosures. It references board and shareholder meeting approvals and compliance with stock exchange disclosure rules. The content is focused on capital management and financing activities rather than financial results, governance changes, or legal matters. The document length is about 7,500 characters, which is substantial but it is not a financial report or earnings release. It is an update on the company's capital use and investment activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-02-27 Chinese
关于使用闲置自有资金购买理财产品进展的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the company's use of idle funds to purchase financial products, including specifics on amounts, counterparties, investment terms, and risk controls. It includes tables of entrusted financial products, their amounts, expected yields, and maturity dates. The document is a disclosure of financing activity related to the company's capital management rather than a financial report or earnings release. It does not contain financial statements or management discussion of results. It is not a report publication announcement since it contains substantive details rather than just a notice of report availability. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage.
2025-02-25 Chinese
2024年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled '2024 年年度业绩快报公告' which translates to '2024 Annual Performance Express Announcement'. It contains preliminary financial data for the year 2024, including revenue, profit, earnings per share, and asset information. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be disclosed in the 2024 Annual Report. The document length is 1803 characters, which is relatively short and typical for a performance express announcement rather than a full annual report. It also includes a risk warning and a note that the detailed audited report will be published later. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only, not the full detailed report. Therefore, the correct classification is Earnings Release (ER). FY 2024
2025-02-25 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is titled as an "Investor Relations Activity Record" from Wuxi Jinghai Amino Acid Co., Ltd. It details an investor relations event held online on February 18, 2025, including participants and Q&A content about competitors and customer concentration. The document is short (628 characters) and focuses on describing an investor relations meeting rather than providing financial statements or detailed financial analysis. It does not contain financial results, audit information, or regulatory filings. It is not a report itself but a record of an investor relations activity. This fits best under the category of Investor Presentation (IP), as it is a detailed presentation for investors focusing on company information and market position, even though it is in a record format rather than a slide deck. The confidence is high given the clear nature of the content and its focus on investor relations activity.
2025-02-18 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held on February 13, 2025, including participants, questions asked, and company responses. The content is a Q&A style summary of an investor meeting or research visit, focusing on company operations, product lines, market strategy, and cost control measures. There are no financial statements, earnings data, or regulatory filings presented. The document is relatively short (1449 characters) and serves as a record of an investor relations activity rather than a formal financial report or announcement. This matches the description of an Investor Presentation (IP) or possibly a Regulatory Filing (RNS). However, since it is a record of an investor relations activity with detailed Q&A, it aligns best with Investor Presentation (IP) category, which includes detailed presentations for investors focusing on financials, strategy, and market position. Confidence is high due to clear content and format.
2025-02-13 Chinese
关于使用闲置自有资金购买理财产品进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of the company's use of idle funds to purchase financial products. It details the amounts, types, and terms of financial products purchased, the authorization process, risk controls, and related disclosures. It is a regulatory disclosure about financing activities, specifically about the company's investment of idle funds in financial products. It does not contain financial statements or comprehensive financial performance data, nor is it a report or transcript. It is not an announcement of voting results, board changes, or legal proceedings. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities related to capital usage and investment products.
2025-02-13 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.